Using Medical Cannabis for Managing Pain in Charcot-Marie-Tooth Disease

by | Feb 23, 2023 | 1 comment

Using Medical Cannabis for Managing Pain in Charcot-Marie-Tooth Disease – Patient Reported Outcomes

Data regarding medical cannabis use for pain relief in CMT from HNF’s CMT Patient Registry, GRIN, was analyzed and published by a team lead by Brian J. Piper, PhD and  Gregory T. Carter, MD. The results revealed the vast majority of those surveyed experienced significant relief, providing evidence that controlled trials are needed to evaluate this pain treatment in CMT further.

Objective: Chronic pain is a major problem for patients with Charcot-Marie-Tooth (CMT) disease. This exploratory study examined patient-reported efficacy of medical cannabis for pain management in this population.

 

Learn more on this topic

Related Blog Posts

HNF is Reshaping Drug Repurposing for CMT

HNF is Reshaping Drug Repurposing for CMT

HNF has partnered with Rarebase, a public benefit precision medicine company that has screened a large library of FDA approved small molecules to identify candidates for various types of CMT. Their tech-enabled drug discovery platform is called Function™. There are many published discoveries on the genetic cause of many types of CMT, including an understanding of the basic mechanism of disease and potential targets for FDA-approved drug repurposing. It is this understanding that allows HNF and Rarebase to target the genetic root cause of CMT.

Join the conversation

Leave a Comment

1 Comment

  1. Linda

    I have been taking CBD medically for about 1/2 year. I have CMT1A, but find no relief from the CBD for pain.But what the CBD what the CBD does is help with nightly restless legs and cramping. Since starting CBD I have experienced no restless legs and very few cramps. The cramps have not totally disappeared but the frequency and severity is much decreased.

    Reply

Submit a Comment

Your email address will not be published. Required fields are marked *

Newsletter

Join for notifications on events, campaigns, & news